Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening
María José Alcaraz García(Jewish General Hospital), Enrique Bernal(Honeywell (United States)), Gabriel Puche(Hospital Reina Sofía de Murcia), Antonia Alcaraz(Hospital Universitario Virgen de la Arrixaca), Alfredo Cano(Hospital Universitario Reina Sofía), Alfredo Minguela, Raúl Teruel‐Montoya(The University of Texas MD Anderson Cancer Center), Alejandro de la Torre(Hospital Reina Sofía de Murcia), Ángeles Muñoz(Hospital Reina Sofía de Murcia), Carlos Báguena(Hospital Reina Sofía de Murcia), Cristina Tomás(Hospital Reina Sofía de Murcia), José A. Campillo
Cited by 8
Related Papers
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176
Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race
|Blood|2014|132